PPA
IDYA icon

Parametric Portfolio Associates’s IDEAYA Biosciences IDYA Stock Holding History

Parametric Portfolio Associates’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,793
Closed -$208K – 3716
2021
Q4 		$208K Buy
+8,793
New +$204K ﹤0.01% 3409

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Parametric Portfolio Associates's IDYA Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of IDEAYA Biosciences (IDYA) in Q1 2022, closing a stake of 8,793 shares — an estimated $208K sold.

Parametric Portfolio Associates first reported a position in IDYA in Q4 2021 and held it in 1 quarter. The position peaked at $208K in Q4 2021. 103 funds tracked by Wall St. Rank hold IDYA as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining IDEAYA Biosciences position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 8,793 IDEAYA Biosciences shares in Q1 2022, an estimated $208K.
  • Parametric Portfolio Associates first reported a position in IDEAYA Biosciences in Q4 2021 and held it in 1 quarter.
  • Parametric Portfolio Associates's IDEAYA Biosciences position peaked at $208K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.